These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34896645)

  • 1. Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial.
    Basnayake C; Kamm MA; Stanley A; Wilson-O'Brien A; Burrell K; Lees-Trinca I; Khera A; Kantidakis J; Wong O; Fox K; Talley NJ; Liew D; Salzberg MR; Thompson AJ
    Clin Gastroenterol Hepatol; 2022 Sep; 20(9):2102-2111.e9. PubMed ID: 34896645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial.
    Basnayake C; Kamm MA; Stanley A; Wilson-O'Brien A; Burrell K; Lees-Trinca I; Khera A; Kantidakis J; Wong O; Fox K; Talley NJ; Liew D; Salzberg MR; Thompson AJ
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):890-899. PubMed ID: 32679040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol.
    Basnayake C; Kamm MA; Salzberg M; Khera A; Liew D; Burrell K; Wilson-O'Brien A; Stanley A; Talley NJ; Thompson AJ
    Contemp Clin Trials; 2019 Sep; 84():105828. PubMed ID: 31437539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study.
    Bray NA; Koloski NA; Jones MP; Do A; Pang S; Coombes JS; McAllister S; Campos J; Arthur L; Stanley P; DeMaria K; Chao CY; Catague R; Whaley A; Talley NJ; Holtmann GJ
    Dig Dis Sci; 2022 Dec; 67(12):5593-5601. PubMed ID: 35362835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM; Jaccard J; Keefer L; Brenner DM; Firth RS; Gudleski GD; Hamilton FA; Katz LA; Krasner SS; Ma CX; Radziwon CD; Sitrin MD
    Gastroenterology; 2018 Jul; 155(1):47-57. PubMed ID: 29702118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
    Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
    Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of care for functional gastrointestinal disorders: A systematic review.
    Basnayake C; Kamm MA; Salzberg MR; Wilson-O'Brien A; Stanley A; Thompson AJ
    J Gastroenterol Hepatol; 2020 Feb; 35(2):204-210. PubMed ID: 31411755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroenterologist Primer: Endometriosis for Gastroenterologists.
    Yu V; McHenry N; Proctor S; Wolf J; Nee J
    Dig Dis Sci; 2023 Jun; 68(6):2482-2492. PubMed ID: 36653576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary interventions for recurrent abdominal pain in childhood.
    Newlove-Delgado TV; Martin AE; Abbott RA; Bethel A; Thompson-Coon J; Whear R; Logan S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010972. PubMed ID: 28334433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Cost Effectiveness of Online Cognitive Behavioral Therapy in Children With Functional Abdominal Pain Disorders.
    Lalouni M; Ljótsson B; Bonnert M; Ssegonja R; Benninga M; Bjureberg J; Högström J; Sahlin H; Simrén M; Feldman I; Hedman-Lagerlöf E; Serlachius E; Olén O
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2236-2244.e11. PubMed ID: 30502501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
    Sperber AD; Freud T; Aziz I; Palsson OS; Drossman DA; Dumitrascu DL; Fang X; Fukudo S; Ghoshal UC; Kellow J; Khatun R; Okeke E; Quigley EMM; Schmulson M; Simren M; Tack J; Whitehead WE; Whorwell P; Bangdiwala SI
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e945-e956. PubMed ID: 34052391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders.
    Rangan V; Singh P; Ballou S; Hassan R; Yu V; Katon J; Nee J; Iturrino J; Lembo A
    Neurogastroenterol Motil; 2022 Apr; 34(4):e14253. PubMed ID: 34520617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
    Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
    J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study.
    Halder SL; Locke GR; Talley NJ; Fett SL; Zinsmeister AR; Melton LJ
    Aliment Pharmacol Ther; 2004 Jan; 19(2):233-42. PubMed ID: 14723614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar.
    Kovács DB; Szekely A; Hubai AG; Palsson O
    BMJ Open Gastroenterol; 2022 Aug; 9(1):. PubMed ID: 35953148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.
    Bensoussan A; Talley NJ; Hing M; Menzies R; Guo A; Ngu M
    JAMA; 1998 Nov; 280(18):1585-9. PubMed ID: 9820260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of irritable bowel syndrome with osteopathy: results of a randomized controlled pilot study.
    Hundscheid HW; Pepels MJ; Engels LG; Loffeld RJ
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1394-8. PubMed ID: 17716344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.